Microfluidic device and uses thereof

Doron Gerber

Microfluidic device and uses thereof

Doron Gerber (Inventor)

The Mina and Everard Goodman Faculty of Life Sciences

Bar-Ilan University

Research output: Patent

Abstract

The present disclosure provides microfluidic test platforms, systems, and methods for manufacturing the disclosed test platforms. The present disclosure further provides uses of the disclosed microfluidic test platforms in personalized medicine. Specifically, in providing prognostic and therapeutic methods for determining drug sensitivity and optimizing treatment regimen for subjects suffering from a pathologic disorder, specifically, cancer.

Original language	English
Patent number	US20210354140A1
State	Published - 18 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://patents.google.com/patent/US20210354140A1/en

Cite this

@misc{b06f5d8531804fe98590178b3cfebf78,

title = "Microfluidic device and uses thereof",

abstract = "The present disclosure provides microfluidic test platforms, systems, and methods for manufacturing the disclosed test platforms. The present disclosure further provides uses of the disclosed microfluidic test platforms in personalized medicine. Specifically, in providing prognostic and therapeutic methods for determining drug sensitivity and optimizing treatment regimen for subjects suffering from a pathologic disorder, specifically, cancer.",

author = "Doron Gerber",

note = "US Patent App. 17/321,142; US20210354140A1",

year = "2021",

month = nov,

day = "18",

language = "الإنجليزيّة",

type = "Patent",

}

TY - PAT

T1 - Microfluidic device and uses thereof

AU - Gerber, Doron

N1 - US Patent App. 17/321,142

PY - 2021/11/18

Y1 - 2021/11/18

N2 - The present disclosure provides microfluidic test platforms, systems, and methods for manufacturing the disclosed test platforms. The present disclosure further provides uses of the disclosed microfluidic test platforms in personalized medicine. Specifically, in providing prognostic and therapeutic methods for determining drug sensitivity and optimizing treatment regimen for subjects suffering from a pathologic disorder, specifically, cancer.

AB - The present disclosure provides microfluidic test platforms, systems, and methods for manufacturing the disclosed test platforms. The present disclosure further provides uses of the disclosed microfluidic test platforms in personalized medicine. Specifically, in providing prognostic and therapeutic methods for determining drug sensitivity and optimizing treatment regimen for subjects suffering from a pathologic disorder, specifically, cancer.

M3 - براءة الإختراع

M1 - US20210354140A1

ER -